News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
66,202 Results
Type
Article (10519)
Company Profile (25)
Press Release (55658)
Section
Business (16641)
Career Advice (1613)
Deals (2848)
Drug Delivery (39)
Drug Development (8405)
Employer Resources (109)
FDA (1688)
Job Trends (2106)
News (31494)
Policy (4555)
Tag
Academia (672)
Alliances (4422)
ALS (12)
Alzheimer's disease (181)
Antibody-drug conjugate (ADC) (15)
Approvals (1670)
Artificial intelligence (18)
Bankruptcy (41)
Best Places to Work (1574)
Biosimilars (13)
Biotechnology (20)
Cancer (94)
Career advice (1314)
Career pathing (21)
Cell therapy (37)
Clinical research (6042)
Collaboration (31)
COVID-19 (727)
Data (69)
Diabetes (20)
Diagnostics (615)
Diversity, equity & inclusion (29)
Drug pricing (37)
Earnings (4501)
Employer resources (98)
Events (7578)
Executive appointments (21)
FDA (1731)
Funding (36)
Gene editing (14)
Gene therapy (36)
GLP-1 (147)
Government (907)
Healthcare (2634)
Infectious disease (736)
Inflammatory bowel disease (14)
Interviews (313)
IPO (1084)
IRA (17)
Job creations (562)
Job search strategy (1098)
Layoffs (84)
Legal (1606)
Lung cancer (23)
Management (40)
Manufacturing (24)
Medical device (1243)
Medtech (1244)
Mergers & acquisitions (1752)
Metabolic disorders (75)
Neuroscience (219)
NextGen Class of 2024 (1239)
Non-profit (941)
Northern California (116)
Obesity (49)
Opinion (158)
Patents (16)
People (5231)
Phase I (2043)
Phase II (2645)
Phase III (2183)
Pipeline (18)
Policy (36)
Postmarket research (249)
Preclinical (786)
Radiopharmaceuticals (18)
Rare diseases (36)
Real estate (798)
Recruiting (44)
Regulatory (2257)
Research institute (519)
Resumes & cover letters (286)
Southern California (89)
Startups (528)
United States (986)
Vaccines (155)
Weight loss (47)
Date
Today (11)
Last 7 days (64)
Last 30 days (320)
Last 365 days (3873)
2024 (3091)
2023 (3967)
2022 (5051)
2021 (5896)
2020 (5785)
2019 (6201)
2018 (4875)
2017 (3634)
2016 (3839)
2015 (4207)
2014 (2804)
2013 (2175)
2012 (2416)
2011 (2473)
2010 (1688)
Location
Africa (319)
Asia (4339)
Australia (855)
California (276)
Canada (84)
China (31)
Connecticut (13)
Europe (8546)
Florida (24)
Illinois (33)
Indiana (13)
Maryland (80)
Massachusetts (160)
New Jersey (60)
New York (72)
North Carolina (49)
Northern California (116)
Ohio (14)
Pennsylvania (54)
South America (345)
Southern California (89)
Texas (34)
Washington State (13)
66,202 Results for "hangzhou just biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Just - Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program
Evotec SE announced that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., was selected by the U.S. Department of Defense to develop an accelerated monoclonal antibody development and manufacturing solution for the DOD’s Manufacturing Optimization Program.
June 25, 2024
·
7 min read
Deals
Broncus has announced the acquisition of the entire interest in Hangzhou Jingliang
Broncus is pleased to announce that, on November 23 2023 Broncus Hangzhou has entered into the Equity Transfer Agreement with the shareholders of the Hangzhou Jingliang, to acquire 100% equity interest in it.
November 23, 2023
·
2 min read
Gold Colloid Co. and Hangzhou Clongene Biotech Enter Strategic Agreement to Bring Rapid In-Vitro Diagnostics and Raw Materials to the US Market
Gold Colloid Co., a leading distributor of medical and diagnostic products in the United States, announced today a strategic partnership with Hangzhou Clongene Biotech Co., Ltd., a renowned Chinese manufacturer of in-vitro diagnostic (IVD) rapid tests and raw materials.
January 12, 2024
·
2 min read
Drug Development
AI Return on Investment: Just Because We Can, Should We?
In this episode, Lori and guests continue their exploratory discussion on AI and focus on the challenges of globalization and return on investment.
September 26, 2024
·
1 min read
·
Lori Ellis
BioForest
Gilead Named One of America’s Most JUST Companies by JUST Capital and CNBC
Gilead Sciences, Inc. announced the company has been named one of America’s Most JUST Companies.
February 9, 2024
·
3 min read
Biotech Bay
Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC
Bristol Myers Squibb is honored to announce it has been recognized as One of America’s Most JUST Companies.
February 5, 2024
·
3 min read
Business
Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz
July 9, 2024
·
5 min read
Gene editing
Gene Editing Startup Tome Struggles to Stay Afloat Just Months After Launching
Despite the promise of its technology and funding from big backers, Tome Biosciences is “operating at reduced capacity” and weighing its “strategic options” as the Massachusetts-based company faces an uncertain future.
August 23, 2024
·
2 min read
·
Tristan Manalac
Sanyou Forms Partnership with Hangzhou Zhongmei Huadong Pharmaceutical, Catalyzing Innovative Drug Research and Development
Recently, Sanyou Biopharmaceuticals Co., Ltd. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Huadong Medicine Co., Ltd., signed a license agreement for a collaboratively developed therapeutic biological product.
June 28, 2023
·
4 min read
Press Releases
Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
October 18, 2024
·
4 min read
1 of 6,621
Next
